USPTO serial 87537995
DATACELERATE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 4, 2018
- Examiner
- GLASSER, CARYN
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with DATACELERATE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
West Conshohocken, PA
West Conshohocken, PA
West Conshohocken, PA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jason M. Vogel
Jason M. Vogel KILPATRICK TOWNSEND & STOCKTON LLP1801 Century Park EastSuite 2300Los Angeles, CA 90067Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting and management in the fields of medicine, pharmaceuticals, clinical and preclinical trials, namely, management and compilation of computerized databases in the field of clinical and preclinical trials for business purposes; providing an on-line database providing business information in the fields of medicine, pharmaceuticals, clinical and preclinical trials; business consulting and management in the fields of medicine, pharmaceuticals, clinical and preclinical trials, namely, clinical and preclinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval | ACTIVE | May 7, 2018 |
| 042 | Providing medical and scientific research information in the fields of medicine, pharmaceuticals, clinical and preclinical trials; providing an on-line searchable database in the fields of medicine, pharmaceuticals, clinical and preclinical trials for scientific research purposes | ACTIVE | May 7, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TransCelerate Biopharma, Inc.
- Other trademarks owned by TransCelerate Biopharma, Inc.
- Other trademarks owned by TransCelerate Biopharma, Inc.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named DATACELERATE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 21, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 21, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 21, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 18, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Sep 4, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 4, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 2, 2018 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 1, 2018 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 23, 2018 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 23, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 28, 2018 | IUAF | USE AMENDMENT FILED | — |
| Jun 28, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 23, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 28, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 28, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 8, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 20, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 20, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 27, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 25, 2017 | NWAP | NEW APPLICATION ENTERED | — |